HLA Typing for Transplant Market Forecast To Reach USD 1,206.02 Million By 2028 Says Reports And Data

The global HLA typing for transplant market size is expected to reach USD 1,206.02 Million by 2028 at a CAGR of 7.0%, according to the latest report by Reports and Data. Increasing prevalence of infectious diseases, rising number of transplant procedures, and growing investment in Human Leukocyte Antigen research are key factors expected to drive market revenue growth over the forecast period. In addition, increasing need for organ transplants due to rising incidence of organ failure due to unhealthy lifestyle and eating habits, and excessive alcohol consumption and drug abuse are other key factors driving revenue growth of the market.

Rising funding and private-public collaboration to boost the scope of HLA research, increasing global burden of infectious diseases, and rapidly growing geriatric population across the globe are key factors expected to drive revenue growth of the market over the forecast period. Rapid shift from serological assays to gene-based HLA typing is expected to further contribute to revenue growth of the market over the forecast period. However, high costs associated with NGS and PCR systems and equipment and unfavorable reimbursement policies regarding organ transplant is expected to restrain market growth to a certain extent over the forecast period.

Leading companies in the global HLA Typing for Transplant market:

Thermo Fisher Scientific, Inc., QIAGEN N.V., Illumina, Inc., CareDx, Inc., Immucor, Inc., Bio-Rad Laboratories, Inc., F. Hoffman-La Roche Ltd., Hologic, Inc., Luminex, Biofortuna, Takara Bio, and Omixon, among others.

Access sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/3976

Some key highlights from the report:

Molecular assays segment is expected to register significant revenue growth over the forecast period owing to increasing advantages of PCR-based molecular assays and growing application of real-time PCR (RT-PCR) in research and diagnostic laboratories.

Instruments segment is expected to register rapid revenue CAGR over the forecast period owing to their enhanced functions and cost-effectiveness. Additionally, development of new technologies has led to production of advanced instruments with longer shelf life and higher accuracy and this is expected to further drive revenue growth of this segment over the forecast period.
Diagnostic segment is expected to register considerable revenue growth over the forecast period owing to increasing use of HLA typing to diagnose rare and chronic disorders and in preimplantation genetic diagnosis.
Hospitals segment revenue is expected to expand considerably over the forecast period owing to increasing number of patients, rising incidence of chronic and lifestyle-induced diseases, and growing number of organ transplants performed in hospitals.

North America accounted for a revenue share of 37.1% in the global market in 2020 and is expected to register significant revenue growth over the forecast period owing to increasing investment in HLA research, rapid advancement in transplant technologies, rising incidence of chronic illnesses, and presence of developed healthcare system in the region…Continue

Request for Custom Research @ https://www.reportsanddata.com/request-customization-form/3976

For the purpose of this report, Reports and Data has segmented the global HLA typing for transplant market based on technology, product, application, end-use, and region:

Technology Outlook (Revenue, USD Million; 2018-2028)

Molecular Assay Technologies

PCR-Based Molecular Assays

Real-time PCR
Sequence-specific Primer-PCR
Sequence-specific Oligonucleotide-PCR
Other PCR-based Molecular Assays
Sequencing-based Molecular Assays
Sanger Sequencing
Next-generation Sequencing
Other Sequencing-based Molecular Assays
Non-molecular Assay Technologies

Product Outlook (Revenue, USD Million; 2018-2028)

Instrument
Reagents
Services
Research Applications

Avail the inside scoop of the Sample report @ https://www.reportsanddata.com/sample-enquiry-form/3976

Application Outlook (Revenue, USD Million; 2018-2028)

Diagnostic Applications

Antibody Screening
Chimerism Monitoring
Others

End-use Outlook (Revenue, USD Million; 2018-2028)

Hospitals
Diagnostic Labs
Academic & Research Institutes

Based On Region: (Revenue, USD Billion, 2018 - 2028)

North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
France
Italy
Rest Of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
South Africa
Rest of MEA

Buy now your Exclusive copy of Report @ https://www.reportsanddata.com/checkout-form/3976

Explore Reports and Data's Prime Analysis of the global Pharma and Healthcare:

Hemophilia Market Size: https://www.reportsanddata.com/report-detail/hemophilia-market

Endotoxin Testing Market Share: https://www.reportsanddata.com/report-detail/endotoxin-testing-market

In-Vitro Toxicology/Toxicity Testing Market Demand: https://www.reportsanddata.com/report-detail/in-vitro-toxicology-toxicity-testing-market

Blood Screening Market Analysis: https://www.reportsanddata.com/report-detail/blood-screening-market

Thank you for reading our report. To know more about the customization of the report or further query about the report, please get in touch with us. Our team will ensure the report is well suited to your requirements.

Contact Us:

John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Read Our Innovative Blogs @ https://www.reportsanddata.com/blogs
Check our upcoming research reports @ https://www.reportsanddata.com/upcoming-reports

About Reports and Data:

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

This release was published on openPR.